These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27501848)

  • 41. Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis.
    Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Mangieri A; Contri R; Stella S; Figini F; Chieffo A; Carlino M; Montorfano M; Colombo A
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1586-94. PubMed ID: 26386758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations Between Target Lesion Restenosis and Drug-Eluting Balloon Use: An Observational Study.
    Lee WC; Wu CJ; Chen YL; Chung WJ; Hsueh SK; Hang CL; Fang CY; Fang HY
    Medicine (Baltimore); 2016 Jan; 95(3):e2559. PubMed ID: 26817908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis.
    Nojima Y; Yasuoka Y; Kume K; Adachi H; Hattori S; Matsutera R; Kohama Y; Sasaki T
    Coron Artery Dis; 2014 Dec; 25(8):638-44. PubMed ID: 25076360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
    Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of Drug-Eluting Stent In-Stent Restenosis With Drug-Eluting Balloons: A Systematic Review and Meta-Analysis.
    Liu S; Worme M; Yanagawa B; Kumar N; Buller CE; Cheema AN; Bagai A
    J Invasive Cardiol; 2018 Oct; 30(10):360-366. PubMed ID: 30108189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis.
    Almalla M; Schröder JW; Pross V; Stegemann E; Marx N; Hoffmann R
    Am J Cardiol; 2011 Aug; 108(4):518-22. PubMed ID: 21624553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis.
    Hehrlein C; Richardt G; Wiemer M; Schneider H; Naber C; Hoffmann E; Dietz U
    EuroIntervention; 2011 May; 7 Suppl K():K119-24. PubMed ID: 22027721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
    Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R;
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial.
    Xu B; Gao R; Wang J; Yang Y; Chen S; Liu B; Chen F; Li Z; Han Y; Fu G; Zhao Y; Ge J;
    JACC Cardiovasc Interv; 2014 Feb; 7(2):204-211. PubMed ID: 24556098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial.
    Loh JP; Stella PR; Sangiorgi G; Silber S; Stahnke S; von Strandmann RP; Torguson R; Waksman R
    Cardiovasc Revasc Med; 2014 Jan; 15(1):23-8. PubMed ID: 24444473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Comparison of Clinical Outcomes After Drug-Eluting Balloon and Drug-Eluting Stent Use for Left Main Bifurcation In-Stent Restenosis.
    Lee WC; Hsueh SK; Chen CJ; Yang CH; Fang CY; Wu CJ; Fang HY
    Int Heart J; 2018 Sep; 59(5):935-940. PubMed ID: 30101849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up.
    Freixa X; Almasood AS; Khan SQ; Wainstein R; Osherov A; Mackie K; Seidelin PH; Džavík V
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):559-65. PubMed ID: 21567881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
    Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
    EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.
    Zhao L; Zhu W; Zhang X; He D; Guo C
    BMC Cardiovasc Disord; 2017 Jan; 17(1):16. PubMed ID: 28061808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In-stent restenosis: the gold standard has changed.
    Chin K
    EuroIntervention; 2011 May; 7 Suppl K():K43-6. PubMed ID: 22027726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
    Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
    Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.